Healthcare & Life Sciences

Mablink Bioscience

Francemerieux-partners.com/investment/mablink/

aliveseries-a

series-a

Stage

Investors

About

Mablink Bioscience develops an innovative chemical masking platform to optimize antibody-drug conjugates (ADCs) aimed at creating more effective and better tolerated treatments for various types of cancer.

Explore Mablink Bioscience's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.